Cancer immunotherapy harnesses the body’s immune system to recognize and eliminate tumor cells. We are interested in:
- Cancer Vaccines: Developed tumor-associated antigens or mRNA-based delivery systems to activate the immune system and elicit a robust, antigen-specific T cell response against cancer cells.
- Immune cell homing materials: Engineered biomaterials that recruit and guide immune cells—such as dendritic cells or T cells—to desired sites, enhancing immune activation, expansion, and targeted tumor cell killing.